Follow the 알테오젠 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 알테오젠 has logged 35 public disclosures. The latest transaction was disclosed on 13 August 2026 (Purchase). Among the most active insiders: 전태연. Every trade is free.
31
Insider Decl.
n/a
Thresholds
n/a
22 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Alteogen es una empresa biofarmacéutica centrada en el desarrollo de fármacos innovadores para el tratamiento del cáncer y otras enfermedades. Cotiza en el mercado XKRX.